UK

Umesh Karshanbhai Mendapara

Active Director Director DIN 07426796
DIN 07426796 First appointment Feb 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2016
Shareholding value - Across - companies

About Umesh Karshanbhai Mendapara

Umesh Karshanbhai Mendapara has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Dominant Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07426796
Primary Designation Director
First Appointment 10 Feb 2016
Oldest Company Age 13 yrs

Current companies

Company Designation Appointment Founded Status
Dominant Pharma Private Limited U24239GJ2013PTC073315
Director 10 Feb 2016 2013 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dominant Pharma Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Umesh Karshanbhai Mendapara

Umesh Karshanbhai Mendapara has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Dominant Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Umesh Karshanbhai Mendapara is associated with 1 company as Director.

Umesh Karshanbhai Mendapara has expertise in General Business.

Umesh Karshanbhai Mendapara has 10 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available